New blood treatment aims to make transfusions safer
NCT ID NCT07015437
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a device called the INTERCEPT Blood System that treats red blood cells to kill germs. Researchers want to see if treated red blood cells survive as well as untreated ones after 35 days of storage. About 70 healthy adults will donate blood, have it treated or not, and then get a small amount back to measure how long the cells last. The goal is to ensure the treated blood is safe and effective for future transfusions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
INTERCEPT Blood System for RBCs (device) and radiolabeled autologous red blood cells
What this could lead to
If successful, this could show that INTERCEPT-treated red blood cells are safe and viable for transfusion, potentially reducing infection risks in blood transfusions.
What could go wrong
This is an early phase 2 study in healthy volunteers, not patients. The treatment may not perform as well as standard RBCs, and results may not translate to real-world transfusion settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
American Red Cross Research Laboratory
RECRUITINGNorfolk, Virginia, 23510, United States
Contact
-
Hoxworth Blood Center
NOT_YET_RECRUITINGCincinnati, Ohio, 45267, United States
Contact